MENU
TRDA
AS OF
Mar 6, 02:47 PM (EDT)
Price
$12.54
Change
+$0.89 (+7.64%)
Capitalization
456.53M
62 days until earnings call
Intraday BUY SELL Signals
Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
May 10, 2023
TRDA's earnings are anticipated to increase 20% to -63 cents per share on May 11.

TRDA's earnings are anticipated to increase 20% to -63 cents per share on May 11.

TRDA, a technology-based company, is scheduled to report its quarterly earnings on May 11. Analysts are expecting a significant rise in earnings, with estimates pointing to a 20% increase, bringing earnings per share (EPS) to -63 cents. The last earnings report on December 31 showed better-than-expected results, with earnings per share of -79 cents, beating the estimate of -83 cents. In this article, we will dive into TRDA's financial ratios and technical indicators to analyze its potential performance after the earnings release.

Sign up for one of these top-performing robots today and start earning more profits in no time!

Key Financial Ratios

  1. Price-to-Book (P/B) Ratio: TRDA's P/B ratio of 1.903 is in line with the industry mean of 23.555, suggesting that the stock is fairly valued relative to its peers.

  2. Price-to-Earnings (P/E) Ratio: The company's P/E ratio of 0.000 is within average values for comparable stocks (124.876), indicating that it is not overpriced based on its earnings.

  3. Projected Growth (PEG Ratio): TRDA's PEG ratio of 0.000 is also within normal values, averaging 3.848, suggesting that the stock's growth prospects are in line with industry standards.

  4. Dividend Yield: The company's dividend yield of 0.000 is around the average of 0.029 among similar stocks, which means that investors can expect a reasonable return on their investment.

  5. Price-to-Sales (P/S) Ratio: TRDA's P/S ratio of 0.000 is also within normal values, averaging 317.511, which implies that the stock is not overvalued based on its sales.

Market Capitalization

With 39.57K shares outstanding, TRDA's current market capitalization sits at $384.64 million. This figure indicates that the company has a reasonable market size, and it has the potential to generate higher revenues in the future.

Technical Analysis

TRDA's 10-day Relative Strength Index (RSI) Indicator recently moved out of the overbought zone on April 18, 2023. This development could signal a shift from an upward trend to a downward trend. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor analyzed 6 instances where the RSI indicator left the overbought zone, and in all cases, the stock moved lower in the days that followed. This puts the odds of a move down at 90%.

Although TRDA's financial ratios are within average values, the recent RSI indicator movement suggests that the stock might experience a downward trend in the short term. Investors should closely monitor the company's earnings release on May 11 and consider their investment strategy accordingly. While the company has demonstrated growth in its last earnings report, the technical indicators point towards potential challenges in the near future.

Related Ticker: TRDA

Momentum Indicator for TRDA turns positive, indicating new upward trend

TRDA saw its Momentum Indicator move above the 0 level on February 19, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 81 similar instances where the indicator turned positive. In of the 81 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for TRDA just turned positive on February 20, 2026. Looking at past instances where TRDA's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

TRDA moved above its 50-day moving average on February 10, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for TRDA crossed bullishly above the 50-day moving average on February 20, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRDA advanced for three days, in of 273 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TRDA moved out of overbought territory on February 27, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 20 similar instances where the indicator moved out of overbought territory. In of the 20 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 49 cases where TRDA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRDA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRDA broke above its upper Bollinger Band on February 25, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRDA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.564) is normal, around the industry mean (29.921). P/E Ratio (10.259) is within average values for comparable stocks, (46.177). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.828). Dividend Yield (0.000) settles around the average of (0.042) among similar stocks. P/S Ratio (20.367) is also within normal values, averaging (315.120).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRDA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

Notable companies

The most notable companies in this group are Regeneron Pharmaceuticals (NASDAQ:REGN), Moderna (NASDAQ:MRNA), Incyte Corp (NASDAQ:INCY), Exelixis (NASDAQ:EXEL), Arrowhead Pharmaceuticals (NASDAQ:ARWR), Adaptive Biotechnologies Corp (NASDAQ:ADPT), Nektar Therapeutics (NASDAQ:NKTR), Sarepta Therapeutics (NASDAQ:SRPT), Novavax (NASDAQ:NVAX), Inovio Pharmaceuticals (NASDAQ:INO).

Industry description

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

Market Cap

The average market capitalization across the Biotechnology Industry is 2.22B. The market cap for tickers in the group ranges from 26 to 123.47B. VRTX holds the highest valuation in this group at 123.47B. The lowest valued company is KRBPQ at 26.

High and low price notable news

The average weekly price growth across all stocks in the Biotechnology Industry was 2%. For the same Industry, the average monthly price growth was 5%, and the average quarterly price growth was 23%. EDSA experienced the highest price growth at 133%, while BSFAF experienced the biggest fall at -96%.

Volume

The average weekly volume growth across all stocks in the Biotechnology Industry was 140%. For the same stocks of the Industry, the average monthly volume growth was 54% and the average quarterly volume growth was 71%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 83
Price Growth Rating: 59
SMR Rating: 92
Profit Risk Rating: 95
Seasonality Score: -19 (-100 ... +100)
View a ticker or compare two or three
TRDA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TRDA showed earnings on February 26, 2026. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
One Design Center Place
Phone
+1 857 520-9158
Employees
159
Web
https://www.entradatx.com
Interact to see
Advertisement
Tickeron, a leader in AI-driven financial tools, today announced exceptional results from its AI Trading Agents, showcasing annualized returns ranging from 102% to 210% across various high-liquidity stocks and strategies.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced groundbreaking performance from its suite of AI Trading Agents. Powered by Financial Learning Models (FLMs), these agents have demonstrated exceptional returns, with top performers achieving annualized gains of up to 83% over periods ranging from 127 to 390 days.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today unveils its Top 10 Day Traders: AI Trading Robots, showcasing exceptional performance in volatile markets. Powered by advanced Financial Learning Models (FLMs), these robots integrate AI with technical analysis to deliver real-time insights for day traders.
#artificial_intelligence
Tickeron, a leader in AI-driven financial solutions, announces groundbreaking performance results for its Crypto AI Trading Robots, achieving annualized returns of up to 85% for ETH.X, 56% for OM.X, and 49% for XRP.X in 2025, powered by advanced Financial Learning Models (FLMs).
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced groundbreaking results from its AI Trading Agents, showcasing annualized returns as high as +84% across various stocks and portfolios.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents. These innovative brokerage agents provide real-time trading signals powered by machine learning, utilizing tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced groundbreaking results from its AI Trading Agents, showcasing exceptional performance in real-time trading signals powered by machine learning. Utilizing tick-level brokerage data and precise trade amounts, these agents operate on 5-, 15-, and 60-minute timeframes to provide traders with actionable insights in volatile markets.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents. These cutting-edge brokerage agents deliver real-time trading signals powered by machine learning, leveraging tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes. Designed to empower traders with superior insights, the agents have demonstrated exceptional performance, including annualized returns as high as 82%.
#artificial_intelligence
The financial markets have undergone a profound transformation in recent years, driven by the integration of artificial intelligence (AI) into trading strategies. As a financial analyst, writer, and AI specialist, one observes that AI trading agents represent a pinnacle of this evolution, blending machine learning algorithms with real-time data analysis to execute trades with unprecedented precision.
#artificial_intelligence
AI trading represents a revolutionary shift in how financial markets operate, combining artificial intelligence, machine learning, and sophisticated algorithmic trading strategies to execute trades with unprecedented precision and speed.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today announced exceptional trading results from its AI Trading Agent focused on Hubbell Incorporated (HUBB). The agent, operating on a 5-minute timeframe, delivered a +105% annualized return, starting from an initial balance of $100,000.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technology, today announced the launch of its advanced AI Trading Agents, delivering real-time trading signals and sophisticated money management for retail and institutional traders. Powered by Financial Learning Models (FLMs) and machine learning, these agents operate across 5-, 15-, and 60-minute timeframes, achieving annualized returns of up to 145% on select portfolios.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, today announced the exceptional performance of its AI Trading Agents, achieving annualized returns of up to 162%, profitable trade percentages as high as 90.51%, and a robust profit factor across multiple assets.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technology, proudly announces the exceptional performance of its AI Trading Agents, delivering annualized returns of up to 188% on a 5-minute timeframe.
#artificial_intelligence
Tickeron, a leader in AI-driven financial tools, today announced the launch of its advanced Pattern Search Engine (PSE), a revolutionary platform that scans 39 distinct trading patterns across stocks, penny stocks, ETFs, crypto, and forex.
#artificial_intelligence
AI trading bots represent the pinnacle of financial technology innovation, transforming how traders and investors interact with global markets.
#artificial_intelligence
As a financial analyst, writer, and AI specialist, I've always pushed for innovations that merge artificial intelligence with actionable trading tools. In the fast-paced world of modern markets, where volatility demands quick decisions, Tickeron's new "My Trades Aggregator (from AI Robots Followed)" aggregator stands out as a revolutionary feature.
#artificial_intelligence#trading
Tickeron, a leading provider of AI-driven trading solutions, is thrilled to announce the exceptional performance of its AI Trading Agents, delivering outstanding results across multiple high-profile stocks.
#artificial_intelligence
Tickeron, a leader in AI-driven financial technologies, today announced groundbreaking results from its AI Crypto Trading Virtual Agents. These innovative tools provide real-time trading signals, integrated money management, and customizable balances, all powered by advanced machine learning algorithms operating on 5-, 15-, and 60-minute timeframes.
#artificial_intelligence
Tickeron, a leading innovator in AI-driven financial technologies, today announced the launch of its advanced AI Trading Brokerage Agents. These cutting-edge tools deliver real-time trading signals powered by machine learning, utilizing tick-level brokerage data and precise trade amounts across 5-, 15-, and 60-minute timeframes.
#artificial_intelligence